APLE vs REGN · P/E 21, rev $1.43B vs P/E 14, rev $14.34B
Apple Hospitality REIT Inc (APLE) versus Regeneron Pharmaceuticals Inc (REGN) — a side-by-side from cached financials, not a winner call.
Apple Hospitality REIT Inc (APLE) is a reit - hotel & motel company listed on US.
Regeneron Pharmaceuticals Inc (REGN) is a biotechnology company listed on US.
Latest reported APLE revenue for 2024-12-31 was $1.43B. Net income was $214.1M. Revenue was up 6.5% from 2023-12-31 to 2024-12-31. APLE currently screens at market cap $3.69B and trailing P/E 21.4.
Latest reported REGN revenue for 2025-12-31 was $14.34B. Net income was $4.50B. Revenue was up 1.0% from 2024-12-31 to 2025-12-31. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
APLE currently screens at market cap $3.69B and trailing P/E 21.4. REGN currently screens at market cap $59.10B and trailing P/E 13.9.
Not investment advice. Open the APLE and REGN stock pages for the full models.
Not investment advice.